Patients Invited into ‘Gentle IVF’ Clinical Study
Midland Fertility is seeking 60 IVF patients to participate in a comparative trial of two tried and tested fertility drugs.
The trial started in March 2014 and, so far, Midland Fertility is delighted to report a clinical pregnancy rate of over 60%.
Midland Fertility is the only UK clinic chosen to participate in the new European-wide study. This follows the success of a previous trial at the Tamworth-based unit, which achieved very positive live birth rates, well above the national average.
To participate, the woman patient should be 38 years old or younger, within a normal weight range, not suffer from polycystic ovaries (PCOS), and have had no more than two earlier IVF egg collections. Tests at Midland Fertility will also establish that she has a normal ovarian reserve. The couples should need either IVF or ICSI treatment, even with donor sperm, but not with surgically retrieved sperm.
“In previous similar multi-centre drug trials, Midland Fertility achieved the highest pregnancy rates,” said nurse manager Mandy Godwin. “So we are delighted to offer patients the chance to benefit from a similar opportunity, which carries no more risks than any standard IVF or ICSI cycle.”
For information about being a part of the trial at Midland Fertility, email the nurses quoting ‘drug trial’ in the subject box, or call 01827 311170.
Issued: 10 March 2014 (updated 30 October 2014)